The team developed a working prototype of the reader that can read a microsensor that is 0.9 millimeters in diameter while implanted underneath the skin using a syringe.

In lab experiments, the reader was able to monitor the rate of breathing and heart rate by detecting subtle movements of the battery-free microsensor. It took two years of research by the team, from ...

Microtech has commenced human clinical trials of its implantable microsensor platform, aimed at measuring atrial pressures critical in managing heart failure. Prof Erez Sharoni of Beilinson ...

TEL AVIV, Israel, Sept. 13, 2022 /PRNewswire/ -- Microtech, a wholly owned subsidiary of Medinol, Inc., a leader in global MedTech research and development, announced that its implantable ...

TEL AVIV, Israel, Dec. 26, 2024 /PRNewswire/ -- Microtech, a wholly owned subsidiary of Medinol Inc., a leader in global MedTech research and development, announced that it has initiated human ...

TEL AVIV, Israel, June 9, 2025 /PRNewswire/ -- Microtech, a wholly owned subsidiary of Medinol, is happy to announce the first U.S. implantations of its atrial-pressure microsensor. Two surgical ...

SAN DIEGO--(BUSINESS WIRE)--Biolinq Incorporated, a healthcare technology company pioneering precision multi-analyte biosensors to improve metabolic health, today announced the completion of $58 ...

The microsensor effort began as a partnership between the Center and ROK ADD in 2018 to successfully meet the stringent form-factor requirements set forth by the customer.

Microtech has commenced human clinical trials of its implantable microsensor platform, aimed at measuring atrial pressures critical in managing heart failure. Prof Erez Sharoni of Beilinson ...

Microtech, a wholly owned subsidiary of Medinol Inc., a leader in global MedTech research and development, announced that it has initiated human clinical trials of their microsensor platform, in a ...